ETF catalog / Other

THNR

Amplify Weight Loss Drug & Treatment ETF

NYSE Arca
Compare this ETF

Inside this portfolio

Identified stock classes20
Matched (%)97.42%
Largest reported stocksPortfolio weight
Novo Nordisk A/S9.76%
Eli Lilly & Co9.26%
Scholar Rock Holding Corp5.71%
Hims & Hers Health Inc5.57%
Viking Therapeutics Inc5.49%
How to read these numbers

The day the fund recorded its holdings.

The share of the fund’s net assets that we could identify as common-stock classes.

Holdings history

9 portfolio dates–

Choose a portfolio date to see which stocks had the largest weights then.

See 3 older reports
Holdings dateMatched (%)Filed (SEC)
98.48%
98.08%
97.63%